Carol Ann Satler
President bij Respira Therapeutics, Inc.
Profiel
Carol Ann Satler is currently the President, Director, and Chief Medical Officer at Respira Therapeutics, Inc. She was previously the President and Chief Executive Officer at Indigo Pharmaceuticals, Inc. She holds a doctorate degree from Case Western Reserve University and an undergraduate degree from Wesleyan University.
Actieve functies van Carol Ann Satler
| Bedrijven | Functie | Begin |
|---|---|---|
Respira Therapeutics, Inc.
 Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM. | President | - |
Eerdere bekende functies van Carol Ann Satler
| Bedrijven | Functie | Einde |
|---|---|---|
Indigo Pharmaceuticals, Inc.
 Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY. | Algemeen Directeur | - |
Opleiding van Carol Ann Satler
| Case Western Reserve University | Doctorate Degree |
| Wesleyan University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Indigo Pharmaceuticals, Inc.
Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY. | Health Technology |
Respira Therapeutics, Inc.
Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM. | Health Technology |
